<table id="Table3" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3. Combined Metformin/Glyburide (Comb) vs Glyburide (Glyb) or Metformin (Met) Monotherapy: Summary of Mean Changes from Baseline* in Fasting Plasma Glucose, HbA<sub>1c</sub> and Body Weight, at Final Visit (29-week study)</caption>
<col align="left" span="1"></col>
<col align="center" span="1"></col>
<col align="center" span="1"></col>
<col align="center" span="1"></col>
<col align="center" span="1"></col>
<col align="center" span="1"></col>
<col align="center" span="1"></col>
<tbody>
<tr>
<th colspan="1"></th>
<th colspan="1"></th>
<th colspan="1"></th>
<th colspan="1"></th>
<th colspan="3">p-values</th>
</tr>
<tr>
<th colspan="1"></th>
<th colspan="1">Comb<br/>(n=213)</th>
<th colspan="1">Glyb<br/>(n=209)</th>
<th colspan="1">GLU<br/>(n=210)</th>
<th colspan="1">Glyb vs<br/>Comb</th>
<th colspan="1">GLU vs<br/>Comb</th>
<th colspan="1">GLU vs<br/>Glyb</th>
</tr>
<tr>
<th colspan="1">Fasting Plasma<br/>Glucose (mg/dL)</th>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>  Baseline<br/>  Change at FINAL VISIT</td>
<td>250.5<br/>-63.5</td>
<td>247.5<br/>13.7</td>
<td>253.9<br/>-0.9</td>
<td>NS**<br/>0.001</td>
<td>NS**<br/>0.001</td>
<td>NS**<br/>0.025</td>
</tr>
<tr>
<th colspan="1">Hemoglobin A<sub>1c</sub> (%)</th>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>  Baseline<br/>  Change at FINAL VISIT</td>
<td>8.8<br/>-1.7</td>
<td>8.5<br/>0.2</td>
<td>8.9<br/>-0.4</td>
<td>NS**<br/>0.001</td>
<td>NS**<br/>0.001</td>
<td>0.007<br/>0.001</td>
</tr>
<tr>
<th colspan="1">Body Weight (lbs)</th>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>  Baseline<br/>  Change at FINAL VISIT</td>
<td>202.2<br/>0.9</td>
<td>203.0<br/>-0.7</td>
<td>204.0<br/>-8.4</td>
<td>NS**<br/>0.011</td>
<td>NS**<br/>0.001</td>
<td>NS**<br/>0.001</td>
</tr>
</tbody>
</table>